InMode (INMD) Shareholder's Equity (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.06 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.20 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn | 661.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 661.25 Mn |
| Dec 31, 2025 | 683.20 Mn |
| Sep 30, 2025 | 653.39 Mn |
| Jun 30, 2025 | 628.44 Mn |
| Mar 31, 2025 | 619.43 Mn |
| Dec 31, 2024 | 703.81 Mn |
| Sep 30, 2024 | 736.89 Mn |
| Jun 30, 2024 | 751.12 Mn |
| Mar 31, 2024 | 815.44 Mn |
| Dec 31, 2023 | 787.37 Mn |
| Sep 30, 2023 | 723.50 Mn |
| Jun 30, 2023 | 666.16 Mn |
| Mar 31, 2023 | 602.98 Mn |
| Dec 31, 2022 | 554.62 Mn |
| Sep 30, 2022 | 508.30 Mn |
| Jun 30, 2022 | 452.81 Mn |
| Mar 31, 2022 | 403.32 Mn |
| Dec 31, 2021 | 415.80 Mn |
| Sep 30, 2021 | 384.03 Mn |
| Jun 30, 2021 | 331.18 Mn |
| Mar 31, 2021 | 293.75 Mn |
| Dec 31, 2020 | 255.48 Mn |
| Sep 30, 2020 | 232.03 Mn |
| Jun 30, 2020 | 205.16 Mn |
| Mar 31, 2020 | 194.83 Mn |
| Dec 31, 2019 | 179.80 Mn |
| Sep 30, 2019 | 160.44 Mn |
| Jun 30, 2019 | 71.61 Mn |
| Dec 31, 2018 | 44.68 Mn |